Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 43rd Annual J.P...
EFFICACY: In the pivotal studies, ADORING 1 and ADORING 2, up to 46% of patients on VTAMA cream achieved vIGA-AD™ treatment success at Week 8 versus 18% of patients on vehicle. POWERFUL SKIN...
Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that the U.S. Food and Drug Administration (FDA) extended by...
（ビジネスワイヤ） -- シャンハイ・ヘンリウス・バイオテック（2696.HK）とオルガノン（NYSE：OGN）は、米国食品医薬品局（FDA）がPROLIA/XGEVA（デノスマブ）の治験中のバイオシミラーであるHLX14の生物学的...
Wie Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) mitteilten, hat die US-amerikanische Arzneimittelzulassungsbehörde FDA (Food and Drug Administration) den BLA-Antrag (Biologic...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.49 | -3.23432343234 | 15.15 | 15.41 | 14.385 | 4006727 | 14.76341137 | CS |
| 4 | -0.365 | -2.42928452579 | 15.025 | 16.29 | 14.385 | 3072506 | 15.26503163 | CS |
| 12 | -4.73 | -24.3940175348 | 19.39 | 19.41 | 14.385 | 2733601 | 16.37516259 | CS |
| 26 | -5.56 | -27.4975272008 | 20.22 | 23.1 | 14.385 | 2183846 | 18.14204726 | CS |
| 52 | 1.12 | 8.2717872969 | 13.54 | 23.1 | 13.14 | 2343297 | 17.87530933 | CS |
| 156 | -15.34 | -51.1333333333 | 30 | 39.475 | 10.835 | 2380754 | 21.84105178 | CS |
| 260 | -19.54 | -57.134502924 | 34.2 | 39.475 | 10.835 | 2474605 | 23.73025449 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
